
Kodikaz Therapeutic Solutions
Pioneering healthcare solutions with a focus on oncology research and clinical development.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | - | |
Total Funding | 000k |
Related Content
Kodikaz operates in the healthcare sector, specializing in oncology research and clinical development. The company is led by a team of experienced professionals, including Anthony Johnson, a seasoned executive with a diverse background in healthcare leadership, and Dr. Leon Bernal Mizrachi, an associate professor in hematology and medical oncology. Kodikaz's business model revolves around developing anti-cancer agents, leveraging the expertise of its scientific advisory board and research team. The company serves clients in the medical and pharmaceutical industries, focusing on innovative treatments and therapies. Revenue is generated through partnerships, research grants, and potential commercialization of successful therapies. Kodikaz's market presence is strengthened by its international perspective, with team members bringing experience from Europe, South America, and the USA. The company aims to advance cancer treatment through cutting-edge research and collaboration with leading institutions.
Keywords: oncology, healthcare, research, clinical development, anti-cancer, partnerships, therapies, international, leadership, pharmaceutical.